<http://webisa.webdatacommons.org/201378706>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<poz.com> .
<http://webisa.webdatacommons.org/201378706>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/229063688>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/201378706> .
<http://webisa.webdatacommons.org/prov/445887086>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/201378706> .
<http://webisa.webdatacommons.org/201378706>	<http://www.w3.org/ns/prov#value>	"Even with appropriate monitoring, there are certainly some additional costs down the road for those who do not seroconvert but do develop osteoporosis, heart, kidney or other problems from taking the treatment." .